Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does FOSAPREPITANT DIMEGLUMINE Cause Headache? 49 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 49 reports of Headache have been filed in association with FOSAPREPITANT DIMEGLUMINE (Fosaprepitant). This represents 5.5% of all adverse event reports for FOSAPREPITANT DIMEGLUMINE.

49
Reports of Headache with FOSAPREPITANT DIMEGLUMINE
5.5%
of all FOSAPREPITANT DIMEGLUMINE reports
27
Deaths
38
Hospitalizations

How Dangerous Is Headache From FOSAPREPITANT DIMEGLUMINE?

Of the 49 reports, 27 (55.1%) resulted in death, 38 (77.6%) required hospitalization, and 30 (61.2%) were considered life-threatening.

Is Headache Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for FOSAPREPITANT DIMEGLUMINE. However, 49 reports have been filed with the FAERS database.

What Other Side Effects Does FOSAPREPITANT DIMEGLUMINE Cause?

Dyspnoea (142) Pyrexia (136) Nausea (130) Infusion related reaction (83) Diarrhoea (80) Vomiting (71) Rash (66) Hypersensitivity (65) Stomatitis (64) Decreased appetite (62)

What Other Drugs Cause Headache?

ADALIMUMAB (19,891) APREMILAST (17,024) ETANERCEPT (14,253) TREPROSTINIL (14,051) METHOTREXATE (11,718) TOFACITINIB (11,061) RITUXIMAB (8,747) TOCILIZUMAB (8,448) INFLIXIMAB (8,387) ABATACEPT (8,184)

Which FOSAPREPITANT DIMEGLUMINE Alternatives Have Lower Headache Risk?

FOSAPREPITANT DIMEGLUMINE vs FOSCARBIDOPA\FOSLEVODOPA FOSAPREPITANT DIMEGLUMINE vs FOSCARNET FOSAPREPITANT DIMEGLUMINE vs FOSFOMYCIN FOSAPREPITANT DIMEGLUMINE vs FOSFOMYCIN TROMETHAMINE FOSAPREPITANT DIMEGLUMINE vs FOSINOPRIL

Related Pages

FOSAPREPITANT DIMEGLUMINE Full Profile All Headache Reports All Drugs Causing Headache FOSAPREPITANT DIMEGLUMINE Demographics